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Background: Age-related macular degeneration (AMD) is considered uncommon in black 
populations including those of Sub-Saharan Africa. The aim of this review was to determine 
the pattern of presentation of AMD in our hospital located in Ibadan, the largest city in 
Sub-Saharan Africa.
Methods: A retrospective review of all cases with AMD presenting to the Eye and Retinal Clinic 
of the University College Hospital, Ibadan, West Africa was undertaken between October 2007 
and September 2010.
Results: In the 3 years reviewed, 768 retinal cases were seen in the hospital, 101 (14%) of 
which were diagnosed with AMD. The peak age was 60–79 years. The male to female ratio was 
approximately 2:3. More males presented with the advanced form of dry AMD than females (odds 
ratio = 2.33). However, more females had advanced wet AMD than males (odds ratio = 1.85). 
Wet AMD was seen in 40 cases (40%).
Conclusion: The review determined that, as AMD is not uncommon and wet AMD is rela-
tively more common in our hospital than has been reported previously, this is probably true of 
Ibadan in general.
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Introduction
Age-related macular degeneration (AMD) is the leading cause of visual impairment 
among elderly white people in the developed world.1 The disease was initially thought 
to be uncommon in people with dark skin living in developing countries,2 but recent 
studies have shown that it is more prevalent in developing countries such as India3 
and Nigeria4 than previously thought. AMD has also been shown to be an important 
cause of poor vision in the western5–7 and southeastern8,9 parts of Nigeria. Adequate 
data are lacking concerning the prevalence of the disease in developing countries. The 
reason for this is connected to the paucity of trained vitreoretinal surgeons and equip-
ment necessary to make accurate diagnoses of this important cause of poor vision and 
blindness in the elderly population. In Sub-Saharan Africa, the number of older people 
is currently increasing due to increased survival rates from improved health facilities; 
hence, the increased number of persons being diagnosed with the disease. The recent 
explosion in published research about this disease suggest its increasing prevalence.
In 2006, we published on our experiences with retinal diseases in our institution and 
the need to establish a vitreoretinal center in the subregion.7 The International Council 
of Ophthalmology, International Agency for the Prevention of Blindness, and a rep-
resentative from Carl Zeiss, Inc, visited our institution and helped initiate sponsored 
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fellowship training in subspecialties including vitreoretinal. 
Furthermore, equipment for subspecialties was purchased 
or donated by the sponsors. The patient load has increased, 
meaning that residents (junior postgraduate doctors) now 
have more cases to learn from. The retina subspecialty is 
fully established.
This review aims to determine if AMD is a problem in 
our hospital, a teaching and tertiary public hospital located 
in Ibadan, the largest city in Sub-Saharan Africa.
Methods
All retinal cases seen in the retina clinic between December   
2007 and December 2010 were reviewed after sub  speciali  zation 
(prior to 2007, ophthalmologists at our hospital were 
nonspecialized; now there are seven subspecialties: retina, 
cornea and anterior segment, glaucoma, orbit and plastic, 
pediatric ophthalmology, neuro-ophthalmology, and 
community ophthalmology). A retina register of all cases seen 
during the period was reviewed. All case notes of patients 
with the diagnosis of AMD were retrieved and included in 
the study.
Criteria for diagnosis
With the aid of slit lamp biomicroscopy using the 78D lens 
and fundus photography, the detection of soft drusen of 
,65 µm with pigmentary changes in the macula indicated 
early age-related maculopathy (ARM). The presence of drusen 
between 65 and 125 µm (size of vein at the disc margin), 
one large druse (125 µm), or multiple large drusen without 
the advanced forms indicated intermediate ARM. Choroidal 
neovascular membrane (CNVM) is suggested by any of the 
following findings: macular scar, retinal pigment epithelium 
(RPE) detachment, subretinal blood, or exudates not accounted 
for by any other disease apart from ARM. CNVM indicated 
an advanced wet ARM, also known as wet AMD. Geographic 
atrophy is a well-demarcated area of macular RPE atrophy of 
at least 175 µm in diameter. This suggests an advanced form 
of dry ARM, also known as dry AMD10 (see Table 1).
Results
In the 3 years under review, 768 retinal cases were seen in 
the hospital, of which 101 (14%) were diagnosed with AMD. 
The peak age was 60–79 years. Patients aged 60–69 and 
70–79 years old constituted two-thirds of the cases (Table 2, 
Figure 1). Early ARM had a steady rise while there was 
more intermediate ARM in the 60–69-years-old age group. 
Late wet ARM occurred mainly in the 60–69 and 70–79 age 
groups. Late dry ARM showed two peaks, in ages 50–59 and 
70–79 years. The 70–79 year age group showed a significant 
proportion of patients with early and late forms of both types 
of AMD. Wet AMD was seen in 40 cases (40%). The male to 
female ratio was about 2:3. More males presented with the 
advanced form of dry AMD than females (odds ratio = 2.33). 
However, more females had advanced wet AMD than males 
(odds ratio = 1.85; see Table 3 and Figure 2).
Table 1 Staging of age-related macular degeneration (AMD)
Stage of AMD Findings
Early ARM Soft drusen of ,65 µm with pigmentary changes  
in the macula
Intermediate  
ARM
Drusen sized from 65 to 125 µm (size of vein at the 
disc margin), presence of one large druse (125 µm), 
or multiple large drusen without the advanced forms
Late dry ARM geographic atrophy (a well-demarcated area of 
macular RPE atrophy at least 175 µm in diameter)
Late wet ARM Choroidal neovascular membrane, macular scar, 
RPE detachment, subretinal blood or exudates not 
accounted for by any other disease apart from ARM
Abbreviations: ARM, age-related maculopathy; RPE, retinal pigment epithelium.
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Figure 1 Age distribution of age-related macular degeneration in Ibadan.
Abbreviation: ARM, age-related maculopathy.
Table 2 Age distribution for AMD in Ibadan
Stage/age (years) 50–59 60–69 70–79 80–89 Total (%)
Early ARM 9 7 14 1 31 (31)
Intermediate ARM – 10 3 – 13 (12.5)
Late dry AMD 6 1 8 2 17 (16.5)
Late wet AMD 2 18 14 6 40 (40)
Total (%) 17 (16.5) 36 (36) 39 (39) 9 (8.5) 101 (100)
Abbreviations:  AMD,  age-related  macular  degeneration;  ARM,  age-related 
maculopathy.
Table 3 Sex distribution of age-related macular degeneration 
(AMD) in Ibadan
Sex/Diagnosis Male Female Total (%)
Early AMD 11 20 31 (31)
Intermediate AMD 5 8 13 (12.5)
Late dry AMD 12 5 17 (16.5)
Late wet AMD 14 26 40 (40)
Total (%) 42 (41.5) 59 (58.5) 101 (100)
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Discussion
AMD is not uncommon and contributes to a significant pro-
portion of ophthalmic presentation in Ibadan, Sub-Saharan 
Africa. This is contrary to previous reports that have suggested 
AMD is uncommon in people of African descent.11–17
The peak age of presentation in this study is similar to that 
in developed countries.1 The sex distribution is also similar 
to previous studies, with a slight female preponderance.1,12,13 
More females presented with early AMD and the late form of 
wet AMD, while more males had advanced dry AMD.
CNVM from AMD was found in about 40% of AMD 
cases, as opposed to previous reports that have shown rates 
between 10% and 20%;7,14,15 this might be related to better 
examination and diagnostic procedures following subspe-
cialization. Dry AMD was still responsible for more of the 
presentations when we consider the early form. Intermediate 
AMD with large drusen occurred in a significant propor-
tion (Figure 3); hence, the need to educate patients about 
the benefit of the vitamin supplements suggested by the 
Age-Related Eye Disease Study.16 This review has shown 
that most patients presented with the advanced stage of the 
disease (Figure 4). With an increasing number of elderly 
people being diagnosed, provision of vision services is 
therefore imperative.
Six patients (two males and four females, with an 
average age of 62 years) presented with breakthrough 
vitreous hemorrhage necessitating vitrectomy. They had 
severe hemorrhagic pigment epithelial detachments similar 
to the cases described for idiopathic polypoidal choroidal 
vasculopathy.18 Indocyanin green angiography is necessary 
to confirm the diagnosis of idiopathic polypoidal choroidal 
vasculopathy, but this was not available in our center. There-
fore, these patients were referred for further evaluation.
Limitations
Our center is relatively new, with few diagnostic tools. The 
presence of fundus fluorescein angiography and optical 
coherence tomography would increase the diagnostic yield 
for occult wet AMD. The study was hospital based, possibly 
producing a higher prevalence of the disease; hence, there 
is a need for a population-based survey.
Conclusion
AMD is a significant issue in Ibadan, Sub-Saharan Africa. 
The need for patients’ education and regular eye examinations 
for the elderly is advocated in Sub-Saharan Africa. A large 
population-based study is warranted to determine the true 
prevalence of the disease.
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Figure 2 Sex distribution of AMD in Ibadan.
Abbreviations: AMD, age-related macular degeneration; int., intermediate.
Figure 3 Large drusen in intermediate AMD.
Figure 4 Partly scarred choroidal neovascular membrane.
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